Skip to content

Optimizing vitamin D supplementation and sun exposure for breastfed infants in Berlin, Germany

An assessment of the minimal amount of vitamin D supplementation and sun exposure required to provide a sufficient vitamin D status in breastfed infants during their first 6 weeks of life

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000919213
Enrollment
40
Registered
2009-10-26
Start date
2000-01-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Background: The rate of non-compliance with vitamin D supplementation in countries of Northern latitude is as high as 45%. Objective: To specify the minimal amount of vitamin D supplementation and sun exposure required to provide a sufficient vitamin D status. Design: 40 infants (World Health Organisation (WHO) skin types I,II) were recruited in Berlin, Germany (Latitude: 52.5 degrees North) during summer (n=20) and winter (n=20) and randomized into equal groups on either 250 units or 500 units of vitamin D3 per day. Outcome measures were: parameters of vitamin D (25(OH)D) and bone metabolism at delivery and 6 weeks later, sun exposure time, UVB dosimetry and surrounding factors including mother’s diet.

Interventions

Supplementation with either 250 or 500 units of vitamin D3 per day for 6 weeks using oral tablets

Sponsors

German Centre for Growth, Development and Preventative Medicine for Children and Adolescents
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to 4 Days
Healthy volunteers
Yes

Inclusion criteria

Healthy breastfed newborns, term-delivery, appropriate for gestational age (AGA), skin type II or III

Exclusion criteria

Vitamin D supplementation during pregnancy, drug abuse, premature delivery, highly pigmented skin (>type III), formula feeding

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026